Biggest News Aggregation in the World
📰 Tango News

Page 88 - Tango News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Tango. Real-time updates on events, politics, business and more.

AngioDynamics (NASDAQ:ANGO) Updates FY 2022 Earnings Guidance

AngioDynamics (NASDAQ:ANGO – Get Rating) updated its FY 2022 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $-0.020-$0.020 for the period, compared to the Thomson Reuters consensus estimate of $-0.010. The company issued revenue guidance of $310 million-$315 million, compared to the consensus revenue estimate of $313.65 million. ANGO has […]
United States Wesley Johnson Thomson Reuters Securities Exchange Commission Zacks Investment Research Angiodynamics Inc

Analysts Issue Forecasts for AngioDynamics, Inc.'s Q4 2022 Earnings (NASDAQ:ANGO)

AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) – Stock analysts at Oppenheimer lowered their Q4 2022 earnings per share (EPS) estimates for shares of AngioDynamics in a research note issued to investors on Friday, April 8th. Oppenheimer analyst S. Lichtman now expects that the medical instruments supplier will post earnings per share of $0.01 for the […]
United States Allspring Global Investments Holdings Polar Capital Holdings Plc Zacks Investment Research Angiodynamics Inc Angiodynamics Company Profile Get Rating

$81.81 Million in Sales Expected for AngioDynamics, Inc. (NASDAQ:ANGO) This Quarter

Equities analysts expect that AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) will post sales of $81.81 million for the current fiscal quarter, according to Zacks. Three analysts have made estimates for AngioDynamics’ earnings. The lowest sales estimate is $81.60 million and the highest is $82.00 million. AngioDynamics reported sales of $76.84 million in the same quarter […]
United States Hong Kong Hightower Advisors Zacks Investment Research Angiodynamics Inc Swiss National Bank

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

AngioDynamics (NASDAQ:ANGO) Updates FY22 Earnings Guidance

AngioDynamics (NASDAQ:ANGO – Get Rating) issued an update on its FY22 earnings guidance on Thursday morning. The company provided earnings per share guidance of ($0.02)-$0.02 for the period, compared to the Thomson Reuters consensus earnings per share estimate of ($0.01). The company issued revenue guidance of $310-315 million, compared to the consensus revenue estimate of […]
United States Jamesc Clemmer Thomson Reuters Securities Exchange Commission Zacks Investment Research Angiodynamics Inc

CNN CNN Newsroom Live June 4, 2024 05:44:00

Cnns nina dos santos looks at how russian oligarchs are reacting to the sanctions. >> reporter: another week, another sanctioned asset seized. on monday, spain took possession of this superyacht, the tango, owned by tycoon viktor vekselberg. t t now in the invasions second month, experts acknowledge the pressure on moscows oligarchs is having a limited effect. >> i for one would certainly like to see a much more vocal community of oligarchs and using what little leverage they have with putin to ...
Nina Dos Santos On Monday Pressure On Moscows Oligarchs Viktor Vekselberg Eastern Ukraine Putin Doesn T

AngioDynamics (NASDAQ:ANGO) Posts Quarterly Earnings Results, Beats Estimates By $0.04 EPS

AngioDynamics (NASDAQ:ANGO – Get Rating) issued its earnings results on Thursday. The medical instruments supplier reported $0.03 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.01) by $0.04, MarketWatch Earnings reports. The company had revenue of $74.00 million for the quarter, compared to analysts’ expectations of $76.32 million. AngioDynamics […]
United States Thomson Reuter Jamesc Clemmer Securities Exchange Commission Squarepoint Ops Zacks Investment Research

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science